Citigroup
ALNA

Citigroup’s Allena Pharmaceuticals ALNA Stock Holding History

Citigroup’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-174,988
Closed -$33K – 6640
2022
Q2 		$33K Buy
174,988
+172,388
+6,630% +$26.7K ﹤0.01% 4747
2022
Q1 		$1K Buy
+2,600
New +$1.08K ﹤0.01% 6260
2019
Q4 		– Sell
-1,307
Closed -$5K – 7871
2019
Q3 		$5K Sell
1,307
-1,821
-58% -$7.82K ﹤0.01% 7365
2019
Q2 		$13K Sell
3,128
-14
-0.4% -$76 ﹤0.01% 7240
2019
Q1 		$22K Buy
3,142
+98
+3% +$711 ﹤0.01% 6918
2018
Q4 		$16K Sell
3,044
-138
-4% -$1.19K ﹤0.01% 6991
2018
Q3 		$34K Buy
3,182
+1,516
+91% +$16.7K ﹤0.01% 6824
2018
Q2 		$22K Buy
1,666
+953
+134% +$13.7K ﹤0.01% 6875
2018
Q1 		$8K Buy
713
+105
+17% +$877 ﹤0.01% 7122
2017
Q4 		$6K Buy
+608
New +$7.49K ﹤0.01% 7205

Other funds holding ALNA

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citigroup's ALNA Position: Q3 2022 in Review

Citigroup sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 174,988 shares — an estimated $33K sold.

Citigroup first reported a position in ALNA in Q4 2017 and held it in 10 quarters. The position peaked at $34K in Q3 2018. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

  • Citigroup reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 174,988 Allena Pharmaceuticals shares in Q3 2022, an estimated $33K.
  • Citigroup first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 10 quarters.
  • Citigroup's Allena Pharmaceuticals position peaked at $34K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.